Daniel C. Javitt - 29 Jul 2022 Form 4 Insider Report for NRX Pharmaceuticals, Inc. (NRXP)

Role
10%+ Owner
Signature
Daniel Javitt
Issuer symbol
NRXP
Transactions as of
29 Jul 2022
Net transactions value
-$791,433
Form type
4
Filing time
02 Aug 2022, 17:43:36 UTC
Previous filing
05 Jul 2022
Next filing
15 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NRXP Common Stock Sale $791,433 -784,063 -7.4% $1.01 9,872,901 29 Jul 2022 by Glytech LLC F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Held by Glytech LLC of which the Reporting Person is the sole owner.